EASTON BIOPHARMACEUTICALS

Wallstreetcn · Mar 16 at 09:28 PM

Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit

Zhitong · Oct 28, 2025 at 04:05 AM

EASTON BIOPHARMACEUTICALS: The company's hydrochloride deoxycorticosterone injection and beraprost sodium tablets are expected to be selected for national centralized drug procurement

Zhitong · Oct 27, 2025 at 06:54 AM

EASTON BIOPHARMACEUTICALS released its performance for the first three quarters, with a net profit attributable to the parent company of 220 million yuan, a year-on-year increase of 1.45%

Zhitong · Oct 17, 2025 at 04:13 AM

EASTON BIOPHARMACEUTICALS: Ailamod Tablets have obtained a drug registration certificate

Zhitong · Oct 17, 2025 at 12:56 AM

SDKX and EASTON BIOPHARMACEUTICALS jointly expand the overseas market for Apalutamide tablets

Zhitong · Sep 28, 2025 at 03:16 AM

EASTON BIOPHARMACEUTICALS: The hydrochloride ephedrine tablets have obtained a drug registration certificate